THE GLP-1 REVOLUTION

GLP-1 medications are rapidly transforming the way millions of people manage their health, lifestyle, and nutrition - and in doing so, are profoundly reshaping consumer behaviour across industries. In this keynote, Brian Robinson, Global Chief Strategy Officer and Head of Growth at Havas Health Network, unpacks the sweeping societal, psychological, and economic impact of GLP-1 therapies.

From reduced grocery spending to new cultural rituals, shifting brand strategies, and widespread changes in consumer priorities, Robinson explores how GLP-1s have become more than a health innovation - they are a cultural and commercial revolution. Drawing on proprietary research and real-world case studies, this presentation offers a powerful look at what happens when a multibillion-dollar appetite changes and why brands can’t afford to ignore it.